Evidence map›Paper›PMID 42631730›Full record

ReviewMedical mycology2026

The future of fungal diagnostics: What's next in laboratory testing for invasive fungal infection?

Rachel Southern-Thomas, Simran Goyal, Anna Louise Wild, Neil Robert Hope Stone

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Medical mycology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Rachel Southern-ThomasDivision of Infection, University College London Hospitals, London, NW1 2PG, UK.ORCID 0009-0008-7967-9576
Simran GoyalDivision of Infection, University College London Hospitals, London, NW1 2PG, UK.
Anna Louise WildDepartment of Clinical Microbiology, Queens Medical Centre, Nottingham, Nottinghamshire, NG7 2UH, UK.
Neil Robert Hope StoneDivision of Infection, University College London Hospitals, London, NW1 2PG, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Invasive fungal infection (IFI) is responsible for millions of deaths globally each year. Prompt diagnosis of IFI is critical, with delay associated with increased mortality. Traditional, culture-based diagnostics are relatively slow and insensitive. Novel molecular techniques, biomarkers and point-of-care tests hope to overcome these limitations. However, these newer methods come with issues of cost, accessibility, and standardisation. This review briefly lays out the current diagnostic landscape, highlights important changes to standards of care, then explores new developments and the future of fungal laboratory diagnosis.

Indexed as

Clinical Laboratory TechniquesDiagnostic Tests, RoutineInvasive Fungal InfectionsMicrobiological TechniquesBiomarkersFungiHumansMolecular Diagnostic TechniquesRapid Diagnostic TestsBiomarkersantifungal agentsfungal diagnosticsinvasive fungal infectionsmicrobiological techniquesmolecular diagnostic techniquesrapid diagnostic tests

Identifiers

PMID42631730
PMCPMC13543316

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.